Inarigivir soproxil

Overview

Inarigivir soproxil (SB9200) is an agonist of innate immunity and shows potent antiviral activity against resistant HCV variants, with EC 50 s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems. Inarigivir soproxil, an orally bioavailable proagent of SB 9000, has broad-spectrum antiviral activity against RNA viruses including HCV , norovirus, respiratory syncytial virus and influenza and HBV .

Application

Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV | Products > Signaling Pathways > HBV

Product Information

• Catalog No.: HY-109035
• CAS No.: 942123-43-5
• Molecular Formula: C25H34N7O13PS
• Molecular Weight: 703.62
• Purity: 99.66%
• Storage: -20°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Solubility: ≥ 5 mg/mL (7.11 mM); Clear solution
• Availability: In-stock

Source

Original product source